NASDAQ:BLFS BioLife Solutions (BLFS) Stock Price, News & Analysis $25.47 +1.75 (+7.38%) (As of 12:12 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get BioLife Solutions alerts: Email Address About BioLife Solutions Stock (NASDAQ:BLFS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioLife Solutions alerts:Sign Up Key Stats Today's Range$24.41▼$25.6950-Day Range$20.72▼$26.5252-Week Range$8.92▼$26.73Volume147,945 shsAverage Volume381,791 shsMarket Capitalization$1.17 billionP/E RatioN/ADividend YieldN/APrice Target$26.20Consensus RatingBuy Company OverviewBioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.Read More… Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. BioLife Solutions Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 33rd PercentileBioLife Solutions scored higher than 33% of companies evaluated by MarketBeat, and ranked 689th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingBuy Consensus RatingBioLife Solutions has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageBioLife Solutions has only been the subject of 3 research reports in the past 90 days.Read more about BioLife Solutions' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for BioLife Solutions are expected to grow in the coming year, from ($0.36) to ($0.12) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioLife Solutions is -16.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioLife Solutions is -16.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioLife Solutions has a P/B Ratio of 3.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about BioLife Solutions' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.90% of the outstanding shares of BioLife Solutions have been sold short.Short Interest Ratio / Days to CoverBioLife Solutions has a short interest ratio ("days to cover") of 10.6, which indicates bearish sentiment.Change versus previous monthShort interest in BioLife Solutions has recently decreased by 7.14%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioLife Solutions does not currently pay a dividend.Dividend GrowthBioLife Solutions does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.90% of the outstanding shares of BioLife Solutions have been sold short.Short Interest Ratio / Days to CoverBioLife Solutions has a short interest ratio ("days to cover") of 10.6, which indicates bearish sentiment.Change versus previous monthShort interest in BioLife Solutions has recently decreased by 7.14%, indicating that investor sentiment is improving significantly. News and Social Media1.5 / 5News Sentiment-0.26 News SentimentBioLife Solutions has a news sentiment score of -0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 23 news articles for BioLife Solutions this week, compared to 3 articles on an average week.Search Interest8 people have searched for BLFS on MarketBeat in the last 30 days. This is an increase of 14% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, BioLife Solutions insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $229,709.00 in company stock.Percentage Held by InsidersOnly 2.20% of the stock of BioLife Solutions is held by insiders.Percentage Held by Institutions93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about BioLife Solutions' insider trading history. Receive BLFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address BLFS Stock News HeadlinesBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Troy Wichterman Sells 611 SharesSeptember 19 at 10:17 AM | insidertrades.comBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Troy Wichterman Sells 828 SharesSeptember 19 at 10:17 AM | americanbankingnews.comUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?September 19, 2024 | Behind the Markets (Ad)BioLife Solutions, Inc. (NASDAQ:BLFS) CRO Garrie Richardson Sells 3,070 Shares of StockSeptember 19 at 8:45 AM | americanbankingnews.comBioLife Solutions, Inc. (NASDAQ:BLFS) Short Interest Down 7.1% in AugustSeptember 18 at 3:43 PM | americanbankingnews.comBioLife Solutions, Inc. (NASDAQ:BLFS) Given Average Recommendation of "Buy" by AnalystsSeptember 15, 2024 | americanbankingnews.comInvesting in BioLife Solutions (NASDAQ:BLFS) a year ago would have delivered you a 78% gainSeptember 5, 2024 | finance.yahoo.comBioLife Solutions Inc (BJX1.DU)August 22, 2024 | sg.finance.yahoo.comSee More Headlines BLFS Stock Analysis - Frequently Asked Questions How have BLFS shares performed this year? BioLife Solutions' stock was trading at $16.25 on January 1st, 2024. Since then, BLFS stock has increased by 46.0% and is now trading at $23.72. View the best growth stocks for 2024 here. How were BioLife Solutions' earnings last quarter? BioLife Solutions, Inc. (NASDAQ:BLFS) announced its quarterly earnings results on Thursday, August, 8th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.08. The medical equipment provider had revenue of $28.33 million for the quarter, compared to the consensus estimate of $23.80 million. BioLife Solutions had a negative trailing twelve-month return on equity of 10.75% and a negative net margin of 59.88%. Who are BioLife Solutions' major shareholders? Top institutional investors of BioLife Solutions include Fred Alger Management LLC (3.43%), William Blair Investment Management LLC (3.41%), Millennium Management LLC (2.19%) and Dimensional Fund Advisors LP (1.73%). Insiders that own company stock include Casdin Partners Master Fund, L, Greef Roderick De, Michael Rice, Aby J Mathew, Karen A Foster, Troy Wichterman, Garrie Richardson, Todd Berard, Geraint Phillips, Sarah Aebersold, Marcus Schulz, Amy Duross and Joseph C Schick. View institutional ownership trends. How do I buy shares of BioLife Solutions? Shares of BLFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of BioLife Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLife Solutions investors own include Micron Technology (MU), AbbVie (ABBV), Cara Therapeutics (CARA), Gilead Sciences (GILD), Pfizer (PFE) and Rigel Pharmaceuticals (RIGL). Company Calendar Last Earnings8/08/2024Today9/19/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:BLFS CUSIPN/A CIK834365 Webwww.biolifesolutions.com Phone(425) 402-1400Fax425-402-1433Employees440Year FoundedN/APrice Target and Rating Average Stock Price Target$26.20 High Stock Price Target$30.00 Low Stock Price Target$22.00 Potential Upside/Downside+10.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-66,430,000.00 Net Margins-59.88% Pretax Margin-51.03% Return on Equity-10.75% Return on Assets-8.89% Debt Debt-to-Equity Ratio0.04 Current Ratio2.86 Quick Ratio1.81 Sales & Book Value Annual Sales$139.96 million Price / Sales7.81 Cash FlowN/A Price / Cash FlowN/A Book Value$7.67 per share Price / Book3.09Miscellaneous Outstanding Shares46,069,000Free Float45,055,000Market Cap$1.09 billion OptionableOptionable Beta1.87 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NASDAQ:BLFS) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredKamala Harris To Tank the Market?URGENT ELECTION MELTDOWN WARNING From the former CIA advisor who predicted President Trump’s win in 2016…Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.